Instruction for use: Cignoderm

Active substance Dithranol

Pharmacological group

dermotropic means

Nosological classification (ICD-10)

L40 Psoriasis

Chronic psoriasis with diffuse plaques, Generalized psoriasis, Psoriasis of the scalp, Psoriasis of the scalp, Generalized form of psoriasis, Psoriasis dermatitis, Psoriasis complicated by erythroderma, Invalidative psoriasis, Isolated psoriatic plaque, Exfoliative psoriasis, Psoriatic Erythroderma, Psoriasis with eczematosis, Hyperkeratosis in psoriasis,Inverse psoriasis,Psoriasis eczematous, Dermatosis of psoriasis, Psoriasis of the genitals, Psoriasis with lesions of hairy areas of skin, Erythrodermal psoriasis, Chronic psoriasis of the scalp, Chronic psoriasis, Ordinary psoriasis, Refractory psoriasis, Kebner phenomenon, Scaly lichen

Composition and form of release

Ointment contains dithranol 0.1%, in tubes of 40 g.

pharmachologic effect

Pharmacological action - antiseptic, antipsoriatic.

Indication

Psoriasis vulgaris.

Contraindications

Acute exfoliating psoriasis with erythroderma, exudative and pustular psoriasis; urolithiasis, pregnancy, age (up to 12 years).

Side effects

Hyperemia, burning, staining of healthy skin and hair in brown.

Dosing and Administration

On skin, apply a thin layer on the affected skin, after 5-30 minutes (in the absence of side effects - after 60 minutes), the ointment is washed with cotton, the skin is washed with warm water with a lot of soap; course no more than 4 weeks.

Precautionary measures

Avoid contact with the face and mucous membranes. To avoid coloring the skin of the hands, the ointment is applied in disposable gloves.

storage Conditions

In the dark place at a temperature of 15-25 ° C.

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.